Andy J. Peniket

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications

The impact of different antimicrobial exposures on the gut microbiome in the ARMORD observational study.

The impact of different antimicrobial exposures on the gut microbiome in the ARMORD observational study.

Journal: eLife
Published: December 10, 2025

COVID-19 infection in adult and paediatric recipients of allogeneic stem cell transplantation: The UK experience.

COVID-19 infection in adult and paediatric recipients of allogeneic stem cell transplantation: The UK experience.

Journal: Leukemia research
Published: July 28, 2024

Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial.

Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial.

Journal: BMJ open
Published: February 05, 2024

Secondary oral squamous cell carcinoma following haematopoietic stem cell transplantation.

Secondary oral squamous cell carcinoma following haematopoietic stem cell transplantation.

Journal: Clinical and experimental dermatology
Published: January 12, 2024

Combination romidepsin and azacitidine therapy is well tolerated and clinically active in adults with high-risk acute myeloid leukaemia ineligible for intensive chemotherapy.

Combination romidepsin and azacitidine therapy is well tolerated and clinically active in adults with high-risk acute myeloid leukaemia ineligible for intensive chemotherapy.

Journal: British journal of haematology
Published: June 28, 2021

Impaired antibody response to COVID-19 vaccination in patients with chronic myeloid neoplasms.

Impaired antibody response to COVID-19 vaccination in patients with chronic myeloid neoplasms.

Journal: British journal of haematology
Published: June 16, 2021

Ixazomib, lenalidomide, and dexamethasone is effective and well tolerated in multiply relapsed (≥2nd relapse) refractory myeloma: a multicenter real world UK experience.

Ixazomib, lenalidomide, and dexamethasone is effective and well tolerated in multiply relapsed (≥2nd relapse) refractory myeloma: a multicenter real world UK experience.

Journal: Leukemia & lymphoma
Published: December 28, 2020

Infection-related morbidity in a large study of transplant non-eligible newly diagnosed myeloma patients treated with UK standard of care.

Infection-related morbidity in a large study of transplant non-eligible newly diagnosed myeloma patients treated with UK standard of care.

Journal: Haematologica
Published: October 15, 2020

A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings?

A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings?

Journal: Leukemia & lymphoma
Published: September 30, 2020

"Is this the GVHD?" A qualitative exploration of quality of life issues in individuals with graft-versus-host disease following allogeneic stem cell transplant and their experiences of a specialist multidisciplinary bone marrow transplant service.

"Is this the GVHD?" A qualitative exploration of quality of life issues in individuals with graft-versus-host disease following allogeneic stem cell transplant and their experiences of a specialist multidisciplinary bone marrow transplant service.

Journal: Health and quality of life outcomes
Published: July 12, 2020

Genomic surveillance of Escherichia coli and Klebsiella spp. in hospital sink drains and patients.

Genomic surveillance of Escherichia coli and Klebsiella spp. in hospital sink drains and patients.

Journal: Microbial genomics
Published: June 20, 2020

Regional outcomes of severe acute respiratory syndrome coronavirus 2 infection in hospitalised patients with haematological malignancy.

Regional outcomes of severe acute respiratory syndrome coronavirus 2 infection in hospitalised patients with haematological malignancy.

Journal: European journal of haematology
Published: May 18, 2020
Showing 1-12 of 42

Last Updated: 09/26/2026